Myoblasts isolated from dysferlinopathy patients or derived from dysferlin-deficient mice proliferated with the normal rate [117,118], but showed decreased fusion efficiency in vitro as a result of activated signaling of the pro-inflammatory network inhibiting myogenesis [118]. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.